A Pharmacokinetic Evaluation Study in Healthy Volunteers

NCT00210093 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-10-16

No results posted yet for this study

Summary

The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous, intranasal, and inhalation administration and to calculate the relative bioavailability of INS37217 when administered via oral or nasal inhalation.

Conditions

  • Healthy

Interventions

DRUG

denufosol tetrasodium (INS37217)

Sponsors & Collaborators

Principal Investigators

  • Amy Schaberg, BSN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2003-05-31
Completion
2003-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00210093 on ClinicalTrials.gov